Tenaya Therapeutics, Inc.
TNYA
Cena:
$ 0.77
-0.02 (-2.53%)
Valuace
70
Růst
45
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES
09-01-2026
AIMS TO BUILD ON POSITIVE 2025 INTERIM TN-201 RESULTS IN FIRST HALF OF 2026 WITH LONGER-TERM FOLLO...
Více zde
TENAYA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING
12-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 11, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING
11-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 11, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS ANNOUNCES RAPID RESOLUTION AND LIFTING OF CLINICAL HOLD FOR MYPEAK-1™ PHASE 1B/2A CLINICAL TRIAL OF TN-201 GENE THERAPY
11-12-2025
MYPEAK-1 PROTOCOL AMENDMENTS AGREED UPON WITH FDA; TENAYA IMPLEMENTING CHANGES WITH SITES MYPEAK-1 P...
Více zde
TENAYA THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
10-11-2025
PRESENTATION OF MYPEAK-1 DATA AND THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS SHOWED CONSISTE...
Více zde
TENAYA THERAPEUTICS PRESENTS PROMISING INTERIM CLINICAL DATA FROM MYPEAK™-1 PHASE 1B/2A CLINICAL TRIAL OF TN-201 GENE THERAPY FOR THE TREATMENT OF MYBPC3-ASSOCIATED HYPERTROPHIC CARDIOMYOPATHY
08-11-2025
MYPEAK-1 DATA PRESENTED DURING LATE-BREAKING SESSION AT AHA SCIENTIFIC SESSIONS 2025 WITH SIMULTANEO...
Více zde
TENAYA THERAPEUTICS ANNOUNCES NEW CLINICAL DATA FOR TN-201 GENE THERAPY WILL BE FEATURED IN LATE-BREAKING PRESENTATION AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
04-11-2025
ORAL PRESENTATION ON SATURDAY TO HIGHLIGHT INTERIM SAFETY AND EFFICACY RESULTS FROM THE MYPEAK™ ...
Více zde
TENAYA THERAPEUTICS TO PARTICIPATE IN H.C. WAINWRIGHT GENETIC MEDICINES VIRTUAL CONFERENCE
09-10-2025
SOUTH SAN FRANCISCO, CALIF., OCT. 09, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS TO PARTICIPATE IN UPCOMING OCTOBER INVESTOR CONFERENCES
02-10-2025
SOUTH SAN FRANCISCO, CALIF., OCT. 02, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
18-09-2025
SOUTH SAN FRANCISCO, CALIF., SEPT. 18, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS TO PARTICIPATE IN THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
02-09-2025
SOUTH SAN FRANCISCO, CALIF., SEPT. 02, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: T...
Více zde
TENAYA THERAPEUTICS PRESENTS INTERIM DATA FROM MYCLIMB™ NATURAL HISTORY STUDY OF MYBPC3-ASSOCIATED HCM PEDIATRIC PATIENTS AT EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2025
31-08-2025
LARGEST NONINTERVENTIONAL NATURAL HISTORY STUDY OF PEOPLE UNDER 18 WITH MYBPC3-ASSOCIATED HCM WITH M...
Více zde
TENAYA THERAPEUTICS TO PARTICIPATE IN THE CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE
08-08-2025
SOUTH SAN FRANCISCO, CALIF., AUG. 08, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: TN...
Více zde
TENAYA THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
06-08-2025
ENROLLMENT COMPLETE IN COHORTS 1 AND 2 OF MYPEAK™ -1 PHASE 1B/2 TRIAL OF TN-201 FOR MYBPC3-ASSOCIA...
Více zde
TENAYA RECEIVES POSITIVE SAFETY REVIEWS FROM INDEPENDENT DSMBS TO ADVANCE BOTH TN-201 AND TN-401 GENE THERAPY CLINICAL TRIALS AS DESIGNED
30-07-2025
ENROLLMENT IN BOTH DOSE COHORTS OF THE MYPEAK™-1 PHASE 1B/2 CLINICAL TRIAL OF TN-201 FOR HYPERTR...
Více zde
TENAYA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
15-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 15, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS INC. (NASDAQ: TNYA...
Více zde
TENAYA THERAPEUTICS TO HIGHLIGHT CAPSID ENGINEERING, GENE EDITING AND MANUFACTURING RESEARCH AT THE ASGCT 28TH ANNUAL MEETING
13-05-2025
ADVANCEMENTS LAY THE GROUNDWORK FOR FUTURE GENETIC MEDICINES FOR RARE AND PREVALENT FORMS OF HEART D...
Více zde
TENAYA THERAPEUTICS PRESENTS INTERIM DATA FROM RIDGE™ NATURAL HISTORY AND SEROPREVALENCE STUDY OF ADULTS WITH PKP2-ASSOCIATED ARVC AT HEART RHYTHM 2025
24-04-2025
RIDGE IS LARGEST NATURAL HISTORY STUDY CONDUCTED WITH MORE THAN 175 PARTICIPANTS ENROLLED TO DATE WI...
Více zde
TENAYA THERAPEUTICS ANNOUNCES LATE BREAKER PRESENTATION OF NEW DATA FROM MYPEAK™-1 PHASE 1B/2 CLINICAL TRIAL OF TN-201 AT AMERICAN COLLEGE OF CARDIOLOGY ANNUAL MEETING
31-03-2025
TN-201 HAS BEEN WELL TOLERATED AT 3E13 VG/KG DOSE NEW BIOPSY DATA REAFFIRM ROBUST TRANSDUCTION AND R...
Více zde
TENAYA THERAPEUTICS PUBLISHES PRECLINICAL DATA DEMONSTRATING TN-201 ENHANCES CARDIAC FUNCTION AND SURVIVAL IN MYBPC3 CARDIOMYOPATHY MODELS
24-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 24, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: T...
Více zde
TENAYA THERAPEUTICS ANNOUNCES LATE BREAKER AND NEW DATA PRESENTATIONS AT THE AMERICAN COLLEGE OF CARDIOLOGY'S ANNUAL SCIENTIFIC SESSION
19-03-2025
LATE BREAKER ORAL PRESENTATION TO INCLUDE NEW DATA FROM COHORT 1 OF THE MYPEAK™-1 PHASE 1B/2 CLINI...
Více zde
TENAYA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
10-03-2025
DOSING INITIATED IN COHORT 2 OF THE MYPEAK™-1 PHASE 1B/2 CLINICAL TRIAL OF TN-201 FOR TREATMENT OF...
Více zde
TENAYA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING
03-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 03, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: T...
Více zde
TENAYA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING
03-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 03, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: T...
Více zde
TENAYA THERAPEUTICS TO PARTICIPATE IN UPCOMING MARCH INVESTOR CONFERENCES
03-03-2025
SOUTH SAN FRANCISCO, CALIF., MARCH 03, 2025 (GLOBE NEWSWIRE) -- TENAYA THERAPEUTICS, INC. (NASDAQ: T...
Více zde
TENAYA THERAPEUTICS RECEIVES $8 MILLION CLINICAL GRANT FROM CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
03-02-2025
FUNDING WILL SUPPORT ONGOING RIDGE™ -1 CLINICAL TRIAL OF TN-401 GENE THERAPY FOR THE POTENTIAL TRE...
Více zde
TENAYA THERAPEUTICS ANNOUNCES 2025 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES
13-01-2025
CONTINUED FOCUS ON DRIVING ADVANCEMENT OF TN-201 AND TN-401 GENE THERAPIES FOR CARDIOMYOPATHIES DO...
Více zde
TENAYA THERAPEUTICS TO ANNOUNCE INITIAL DATA FROM MYPEAK-1 PHASE 1B/2 CLINICAL TRIAL OF TN-201 GENE THERAPY FOR MYBPC3-ASSOCIATED HYPERTROPHIC CARDIOMYOPATHY ON TUESDAY, DECEMBER 17, 2024
16-12-2024
COMPANY TO HOST CONFERENCE CALL ON TUESDAY, DECEMBER 17, AT 8:00 A.M. ET COMPANY TO HOST CONFERENCE ...
Více zde
TENAYA THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
06-11-2024
DATA SAFETY AND MONITORING BOARD ENDORSED DOSE ESCALATION AND BROADENING OF INCLUSION CRITERIA IN TH...
Více zde
TENAYA THERAPEUTICS ANNOUNCES UPDATES ON TN-201 GENE THERAPY PROGRAM FOR MYBPC3-ASSOCIATED HCM
17-10-2024
INDEPENDENT DATA SAFETY AND MONITORING BOARD ENDORSED DOSE ESCALATION AND BROADENING OF ELIGIBILITY ...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-01-30 00:00:00 | 8-K |  | Stáhnout |
| 2026-01-02 00:00:00 | 8-K | | Stáhnout |
| 2025-12-12 00:00:00 | 8-K | | Stáhnout |
| 2025-12-11 00:00:00 | 8-K | | Stáhnout |
| 2025-11-10 00:00:00 | 8-K | | Stáhnout |
| 2025-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2025-11-07 00:00:00 | 8-K | | Stáhnout |
| 2025-08-06 01:00:00 | 8-K | | Stáhnout |
| 2025-08-06 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-06 00:00:00 | 8-K | | Stáhnout |
| 2025-08-06 00:00:00 | 10-Q | | Stáhnout |
| 2025-05-30 01:00:00 | 8-K | | Stáhnout |
| 2025-05-30 00:00:00 | 8-K | | Stáhnout |
| 2025-05-07 01:00:00 | 8-K | | Stáhnout |
| 2025-05-07 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-07 00:00:00 | 8-K | | Stáhnout |
| 2025-05-07 00:00:00 | 10-Q | | Stáhnout |
| 2025-04-18 01:00:00 | 8-K | | Stáhnout |
| 2025-04-18 00:00:00 | 8-K | | Stáhnout |
| 2025-03-28 00:00:00 | 8-K | | Stáhnout |
| 2025-03-27 23:00:00 | 8-K | | Stáhnout |
| 2025-03-10 00:00:00 | 8-K | | Stáhnout |
| 2025-03-10 00:00:00 | 10-K | | Stáhnout |
| 2025-03-09 23:00:00 | 8-K | | Stáhnout |
| 2025-03-09 23:00:00 | 10-K | | Stáhnout |
| 2025-03-04 00:00:00 | 8-K | | Stáhnout |
| 2025-03-03 23:00:00 | 8-K | | Stáhnout |
| 2025-02-07 00:00:00 | 8-K | | Stáhnout |
| 2025-02-06 23:00:00 | 8-K | | Stáhnout |
| 2025-01-28 00:00:00 | 8-K | | Stáhnout |
| 2025-01-27 23:00:00 | 8-K | | Stáhnout |
| 2024-12-17 00:00:00 | 8-K | | Stáhnout |
| 2024-12-16 23:00:00 | 8-K | | Stáhnout |
| 2024-11-06 00:00:00 | 8-K | | Stáhnout |
| 2024-11-06 00:00:00 | 10-Q | | Stáhnout |
| 2024-11-05 23:00:00 | 8-K | | Stáhnout |
| 2024-11-05 23:00:00 | 10-Q | | Stáhnout |
| 2024-09-16 01:00:00 | 8-K | | Stáhnout |
| 2024-09-16 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-08 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2024-07-25 01:00:00 | 8-K | | Stáhnout |
| 2024-07-25 00:00:00 | 8-K | | Stáhnout |
| 2024-06-27 01:00:00 | 8-K | | Stáhnout |
| 2024-06-27 00:00:00 | 8-K | | Stáhnout |
| 2024-05-31 01:00:00 | 8-K | | Stáhnout |
| 2024-05-31 00:00:00 | 8-K | | Stáhnout |
| 2024-05-14 01:00:00 | 8-K | | Stáhnout |
| 2024-05-14 01:00:00 | 10-Q | | Stáhnout |
| 2024-05-14 00:00:00 | 8-K | | Stáhnout |
| 2024-05-14 00:00:00 | 10-Q | | Stáhnout |
| 2024-03-18 00:00:00 | 8-K | | Stáhnout |
| 2024-03-18 00:00:00 | 10-K | | Stáhnout |
| 2024-03-17 23:00:00 | 8-K | | Stáhnout |
| 2024-03-17 23:00:00 | 10-K | | Stáhnout |
| 2024-02-08 00:00:00 | 8-K | | Stáhnout |
| 2024-02-07 23:00:00 | 8-K | | Stáhnout |
| 2023-11-08 00:00:00 | 8-K | | Stáhnout |
| 2023-11-08 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-07 23:00:00 | 8-K | | Stáhnout |
| 2023-11-07 23:00:00 | 10-Q | | Stáhnout |
| 2023-08-09 01:00:00 | 8-K | | Stáhnout |
| 2023-08-09 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-09 00:00:00 | 8-K | | Stáhnout |
| 2023-08-09 00:00:00 | 10-Q | | Stáhnout |
| 2023-06-12 01:00:00 | 8-K | | Stáhnout |
| 2023-06-12 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 10-Q | | Stáhnout |
| 2023-05-10 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 00:00:00 | 10-Q | | Stáhnout |
| 2023-03-21 00:00:00 | 8-K | | Stáhnout |
| 2023-03-20 23:00:00 | 8-K | | Stáhnout |
| 2023-03-13 00:00:00 | 8-K | | Stáhnout |
| 2023-03-12 23:00:00 | 8-K | | Stáhnout |
| 2023-03-08 00:00:00 | 8-K | | Stáhnout |
| 2023-03-08 00:00:00 | 10-K | | Stáhnout |
| 2023-03-07 23:00:00 | 8-K | | Stáhnout |
| 2023-03-07 23:00:00 | 10-K | | Stáhnout |
| 2022-12-07 00:00:00 | 8-K | | Stáhnout |
| 2022-12-06 23:00:00 | 8-K | | Stáhnout |
| 2022-11-17 00:00:00 | 8-K | | Stáhnout |
| 2022-11-16 23:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2022-11-09 23:00:00 | 8-K | | Stáhnout |
| 2022-11-09 23:00:00 | 10-Q | | Stáhnout |
| 2022-08-10 01:00:00 | 8-K | | Stáhnout |
| 2022-08-10 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-10 00:00:00 | 8-K | | Stáhnout |
| 2022-08-10 00:00:00 | 10-Q | | Stáhnout |
| 2022-06-10 01:00:00 | 8-K | | Stáhnout |
| 2022-06-10 00:00:00 | 8-K | | Stáhnout |
| 2022-05-11 01:00:00 | 8-K | | Stáhnout |
| 2022-05-11 01:00:00 | 10-Q | | Stáhnout |
| 2022-05-11 00:00:00 | 8-K | | Stáhnout |
| 2022-05-11 00:00:00 | 10-Q | | Stáhnout |
| 2022-03-23 00:00:00 | 8-K | | Stáhnout |
| 2022-03-23 00:00:00 | 10-K | | Stáhnout |
| 2022-03-22 23:00:00 | 8-K | | Stáhnout |
| 2022-03-22 23:00:00 | 10-K | | Stáhnout |
| 2021-12-22 00:00:00 | 8-K | | Stáhnout |
| 2021-12-21 23:00:00 | 8-K | | Stáhnout |
| 2021-11-22 00:00:00 | 8-K | | Stáhnout |
| 2021-11-21 23:00:00 | 8-K | | Stáhnout |
| 2021-11-10 00:00:00 | 8-K | | Stáhnout |
| 2021-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2021-11-09 23:00:00 | 8-K | | Stáhnout |
| 2021-11-09 23:00:00 | 10-Q | | Stáhnout |
| 2021-09-08 01:00:00 | 8-K | | Stáhnout |
| 2021-09-08 01:00:00 | 10-Q | | Stáhnout |
| 2021-09-08 00:00:00 | 8-K | | Stáhnout |
| 2021-09-08 00:00:00 | 10-Q | | Stáhnout |
| 2021-08-03 01:00:00 | 8-K | | Stáhnout |
| 2021-08-03 00:00:00 | 8-K | | Stáhnout |
